summit of BRICS countries -- Brazil, Russia, India, China and South Africa -- and the Boao Forum for Asia on the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ASIA PHARMACEUTICALS
India, China and other parts of Asia are the new frontier for the world's drugmakers. Biotech and pharmaceutical companies are doing more trials and drug-discovery research in the region. And local drugmakers are trying to become global players.
Asia Pharmaceuticals is part of Business Exchange, suggested by
Bruce Einhorn.
This topic contains
534 news
and
10 blog
items.
Read updated news, blogs, and resources about Asia Pharmaceuticals. Find user-submitted articles and reactions on Asia Pharmaceuticals from
like-minded professionals.
News
Please add new articles to this topic
key risk to economy Interest rate hike 'to fight inflation' The 24 groups represent businesses including agriculture,...
at www.affymetrix.com. About Affymetrix Affymetrix technology is used by the world's top pharmaceutical, diagnostic,...
Atlas Venture until 2000 and Dinko Valerio PhD, the founder and former CEO of Crucell, a Euronext/ NASDAQ-listed...
Hu also urged stronger high-tech cooperation between the two countries, calling for cooperation on areas like clean...
Co., a midsize insurance company; Huaneng Renewables Corp., an alternative energy producer; New Century Shipbuilding Co.
is one of the richest women in India. She is the founder of Biocon, a biotech company and Asia's largest insulin maker.
Press Releases Market Activity American Medical Systems Holdings Inc.| AMMD Endo Pharmaceutical Holdings Inc.
LONDON: GW Pharmaceuticals has signed up Novartis to sell its cannabis-based drug Sativex in a range of markets,...
* Novartis to sell drug in Australia, Asia, Mideast, Africa * GW to get $5 mln upfront, plus up to $28.
Shares in GW Pharmaceuticals rocketed yesterday after the British biotech firm said it had signed a key deal with Swiss...
* Novartis to sell drug in Australia, Asia, Mideast, Africa * GW to get $5 mln upfront, plus up to $28.
* Novartis to market drug in Asia, Mid-East, Africa * GW to receive $5 mln upfront, plus $28.75 mln milestones.
"Friday's negative leads from Wall Street combined with a mixed start to the week so far from Asia is paving the...
opt-in/opt-out and government laws, rules and regulations. Campaign-specific best practices and principles, such as...
is one of the richest women in India. She is the founder of Biocon, a biotech company and Asia's largest insulin maker.
used in polyolefin production. This product is currently supplied to the region from Albemarle's facilities in Europe,...
company CEOs were of the opinion that consumer-driven models could "reap a bumper harvest, since China and South...
development program for VEGF Trap-Eye TARRYTOWN, N.Y. and BERLIN, April 8, 2011 /PRNewswire via COMTEX/ -- Regeneron...
Robert Haag, Managing Director of HGR in Asia, to Speak on the Importance of Investor Relations in Panel on Alternative...
Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema, issued April 8, 2011 by Regeneron...
Company's global headquarters is located in California, USA, with manufacturing facilities in India. SOHM, Inc.
second quarter, ranging from global brand names to miners to pharmaceutical firms. With funds flowing back in to Asia...
April 7 (Bloomberg) -- Valeant Pharmaceuticals International Inc. Chief Executive Officer J. Michael Pearson has built...
Code for Integrated Healthcare Holdings Ltd in paragraph 1.) The healthcare holding company that owns leading hospitals...
Top Sources: Asia Pharmaceuticals
- SeekingAlpha.com
- pharma-iq.com
- Economictimes
- Reuters
- content.nejm.org
- TheStreet.com
- MarketWatch
- Globe Investor
- pennystockdd.com
- MSNBC
account